13.78
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NVCR Giù?
Forum
Previsione
Novocure Ltd Borsa (NVCR) Ultime notizie
New TTFields Data Presentations Might Change The Case For Investing In NovoCure (NVCR) - simplywall.st
How NovoCure Limited stock benefits from global expansionWeekly Stock Summary & Weekly Watchlist of Top Performers - Trung tâm Dự báo KTTV quốc gia
NovoCure Ltd. Hits Day High with Strong 7.67% Intraday Surge - Markets Mojo
Why NovoCure Limited stock is rated strong buyAnalyst Downgrade & Daily Price Action Insights - newser.com
NovoCure Limited stock volume spike explainedWeekly Stock Recap & Weekly Return Optimization Alerts - newser.com
Novocure to present tumor treating fields data at upcoming oncology congresses - Investing.com Australia
Novocure to Present New Research for Tumor Treating Fields (TTFields) Therapy at European Association of Neuro-Oncology (EANO) Meeting and the European Society for Medical Oncology (ESMO) Congress - Yahoo Finance
Tumor Treating Fields Market Demand, Growth, and Future Scope (2025-2032) Featuring Novocure GmbH and Zai Lab - openPR.com
How to manage a losing position in NovoCure LimitedStop Loss & Momentum Based Trading Signals - newser.com
Is NovoCure Limited stock ready for a breakoutWeekly Trend Report & High Conviction Buy Zone Picks - newser.com
What sentiment indicators say about NovoCure Limited stockTrade Risk Assessment & Daily Volume Surge Signals - newser.com
Should you wait for a breakout in NovoCure LimitedPortfolio Performance Summary & Stepwise Trade Execution Plans - newser.com
NovoCure (NVCR): Evaluating Valuation as METIS Phase 3 Brain Metastases Results Reach Industry Conference Milestone - simplywall.st
Using data tools to time your NovoCure Limited exitJuly 2025 Trends & Target Return Focused Stock Picks - newser.com
NovoCure's (NVCR) Sell (E+) Rating Reiterated at Weiss Ratings - MarketBeat
Final METIS Trial Results for TTFields Therapy Could Be a Game Changer for NovoCure (NVCR) - Sahm
Should I buy NovoCure Limited (038) stock before earnings seasonJuly 2025 Short Interest & Accurate Buy Signal Alerts - newser.com
Why NovoCure Limited (038) stock remains top ratedEarnings Summary Report & Free Weekly Chart Analysis and Trade Guides - newser.com
NovoCure Ltd. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
NovoCure (NASDAQ:NVCR) vs. Evogene (NASDAQ:EVGN) Head-To-Head Analysis - Defense World
NovoCure Limited (NVCR) Stock Analysis: A Closer Look at an 87.5% Potential Upside in the Medical Device Sector - DirectorsTalk Interviews
NovoCure Limited (NASDAQ:NVCR) Given Average Recommendation of “Hold” by Analysts - Defense World
Evercore Maintains Novocure(NVCR.US) With Buy Rating, Cuts Target Price to $25 - 富途牛牛
Published on: 2025-10-05 04:02:03 - newser.com
Analyzing NovoCure Limited with multi timeframe chartsQuarterly Trade Report & Low Volatility Stock Recommendations - newser.com
NovoCure (NVCR): Assessing Valuation After Positive Phase 3 METIS Trial Results Unveiled - simplywall.st
Volume spikes in NovoCure Limited stock – what they mean2025 Support & Resistance & Capital Protection Trading Alerts - newser.com
Will NovoCure Limited (038) stock keep high P E multiplesRecession Risk & Safe Entry Trade Signal Reports - newser.com
Why NovoCure (NVCR) Is Up 9.9% After Phase 3 METIS Trial Success in Brain Metastases - simplywall.st
How NovoCure Limited (038) stock responds to job market shiftsJuly 2025 Outlook & Short-Term High Return Strategies - newser.com
Medical Technology Firm Novocure Schedules Q3 2025 Financial Results with Investor Conference Call - Stock Titan
Novocure to Report Third Quarter 2025 Financial Results - The Globe and Mail
Why NovoCure Limited is moving todayQuarterly Earnings Report & Low Risk High Reward Trade Ideas - newser.com
NovoCure stock rating reiterated at Buy by H.C. Wainwright on METIS trial data - Investing.com Nigeria
NovoCure's (NVCR) "Neutral" Rating Reaffirmed at Wedbush - MarketBeat
Pattern recognition hints at NovoCure Limited upsideTrade Volume Report & Real-Time Chart Breakout Alerts - newser.com
Novocure (NVCR) Announces Positive Phase 3 METIS Trial Results - GuruFocus
Novocure’s cancer therapy delays brain metastases progression By Investing.com - Investing.com Australia
Novocure’s cancer therapy delays brain metastases progression - Investing.com India
15-Month Brain Metastases Control: Novocure's TTFields Therapy Shows Breakthrough in Lung Cancer Trial - Stock Titan
Live market analysis of NovoCure LimitedJuly 2025 Selloffs & Safe Entry Point Identification - newser.com
Washington Capital Management Inc. Invests $374,000 in NovoCure Limited $NVCR - MarketBeat
How NovoCure Limited stock benefits from strong dollarJuly 2025 Patterns & Risk Controlled Swing Alerts - newser.com
Regression analysis insights on NovoCure Limited performancePortfolio Risk Report & Fast Gain Swing Alerts - newser.com
Published on: 2025-09-28 23:33:37 - newser.com
NovoCure Limited stock outlook for YEARJuly 2025 Intraday Action & Fast Gain Stock Tips - newser.com
Is NovoCure Limited (038) stock a buy on weaknessJuly 2025 Action & Technical Pattern Based Buy Signals - newser.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):